Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-16

FDA Approved: GLATIRAMER ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for glatiramer acetate from Sun Pharmaceutical Industries, expanding the approval of a generic product under ANDA206…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)